fluorescein-5-isothiocyanate and Mast-Cell Sarcoma

fluorescein-5-isothiocyanate has been researched along with Mast-Cell Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buelow, R; Fanget, L; Gao, L; Lussow, AR; Peretto, S; Pouletty, P	1

Other Studies

1 other study(ies) available for fluorescein-5-isothiocyanate and Mast-Cell Sarcoma

Article	Year
Redirecting circulating antibodies via ligand-hapten conjugates eliminates target cells in vivo. Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 1996, Volume: 19, Issue:4 Topics: Animals; Antibodies; Antibody Specificity; Antigen-Antibody Complex; Antilymphocyte Serum; Complement System Proteins; Cytotoxicity, Immunologic; Female; Fluorescein-5-isothiocyanate; Haptens; Immunotherapy; Ligands; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; T-Lymphocytes; Tumor Cells, Cultured	1996

Article

Year

Redirecting circulating antibodies via ligand-hapten conjugates eliminates target cells in vivo.

Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 1996, Volume: 19, Issue:4

Topics: Animals; Antibodies; Antibody Specificity; Antigen-Antibody Complex; Antilymphocyte Serum; Complement System Proteins; Cytotoxicity, Immunologic; Female; Fluorescein-5-isothiocyanate; Haptens; Immunotherapy; Ligands; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; T-Lymphocytes; Tumor Cells, Cultured

1996